Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01510327
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown 
Has Results
PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Element Everolimus-Eluting Coronary Stent System;   Drug: Aspirin;   Drug: Thienopyridine

Study has passed its completion date and status has not been verified in more than two years.